Thymosin Alpha-1

Human clinical Immune Support In 1 protocol 3 sources

Thymosin Alpha-1 is a naturally occurring peptide produced by the thymus gland that plays a vital role in modulating the immune system. Research demonstrates its ability to enhance T-cell function, improve vaccine response, and support the body's defense against viral infections and certain cancers.

01Dosing reference

Amount

1.5 mg

Frequency

2 times per week

Cycle

4-12 weeks depending on the research protocol

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

T-Cell Maturation

Stimulates the development and maturation of T-cells within the thymus gland.

Cytokine Production

Increases the production of key cytokines like interferon-gamma and interleukin-2, which coordinate the immune response.

Immune Modulation

Enhances the body's ability to fight off viral infections and cellular abnormalities by boosting cell-mediated immunity.

03Human evidence

Improved outcomes in chronic hepatitis B and C infections.

Multiple clinical trials have shown that Thymosin Alpha-1, often used alongside other antivirals, helps reduce viral load and normalize liver enzymes.

Enhanced immune response to vaccines in immunocompromised individuals.

Studies in elderly patients and those with weakened immune systems demonstrated higher antibody titers when TA1 was administered alongside influenza vaccines.

04Preclinical evidence

Inhibition of tumor growth in melanoma and lung cancer models.

Animal studies indicate that TA1 can enhance the efficacy of chemotherapy and reduce tumor size by boosting anti-tumor immune responses.

Protection against sepsis-induced immune suppression.

In mouse models of severe infection, TA1 administration prevented the apoptosis of immune cells and improved survival rates.

05What is known vs. unknown

Reasonably established

Naturally produced in the thymus gland to regulate immunity.
Approved as a prescription medication (Zadaxin) in over 30 countries for viral infections.
Enhances the function of dendritic cells and T-cells.
Often researched for its potential to mitigate autoimmune conditions by balancing immune responses.

Unknowns & limits

Optimal dosing protocols for chronic autoimmune conditions remain undefined.
Long-term safety data in healthy individuals using it for general immune enhancement is limited.
Not approved by the US FDA for general use, though it has received orphan drug status for specific conditions.

06Safety & regulatory context

Regulatory statusThymosin Alpha-1 is generally well-tolerated in clinical settings, with mild side effects such as redness or irritation at the injection site. It is contraindicated in individuals with organ transplants or those on immunosuppressive therapy, as it stimulates the immune system. While approved as a pharmaceutical (Zadaxin) in many countries for treating hepatitis and as a vaccine adjuvant, it is not FDA-approved for general use in the United States and is often studied under orphan drug designations.

07Compared with LL-37

Thymosin Alpha-1 vs. LL-37

Key difference

Thymosin Alpha-1 primarily modulates and enhances the body's own adaptive immune response (T-cells), whereas LL-37 is an antimicrobial peptide that directly attacks pathogens and modulates innate immunity.

When researchers discuss each

TA1 is discussed when the goal is to correct immune dysfunction or boost viral defense, while LL-37 is researched for direct antibacterial properties and wound healing.

08Appears in protocols

🛡️ Immune Defense Protocol

1.5 mg 2x/week2x per week

09Glossary

T-cells

A type of white blood cell that is at the core of adaptive immunity, responsible for identifying and destroying infected or cancerous cells.

Cytokines

Small proteins released by cells that have a specific effect on the interactions and communications between cells, particularly in immune responses.

Adjuvant

A substance that enhances the body's immune response to an antigen, often used in vaccines.

10Knowledge check

Q1What is the primary mechanism by which Thymosin Alpha-1 enhances the immune system?

Q2In which patient population is Thymosin Alpha-1 generally contraindicated?

Q3Which conclusion about long-term safety of Thymosin Alpha-1 in healthy people is best supported by the dossier evidence?

Q4According to the dossier, what is the key difference between Thymosin Alpha-1 and LL-37 that guides researchers' choice between them?

Q5Which regulatory or safety statement about Thymosin Alpha-1 is supported by the dossier?

11Sources

More in Immune Support

See all

LL-37

Immune Support

Early human

LL-37 is the only human cathelicidin antimicrobial peptide, naturally produced by the body's immune cells. Research shows it possesses broad-spectrum antimicrobial properties against bacteria, fungi, and viruses, while also playing a crucial role in immune modulation, reducing inflammation, and accelerating wound healing.

100-250 mcg/day

Vasoactive Intestinal Peptide

Immune Support

Human clinical

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide that functions as a potent vasodilator, immune regulator, and neurotransmitter. Research highlights its ability to reduce inflammation, regulate immune responses, and improve respiratory and cardiovascular conditions.

50-100 mcg (nasal spray) or continuous IV infusion in clinical settings

PNC-27

Immune Support

Preclinical only

PNC-27 is a synthetic peptide designed to target and destroy cancer cells by binding to the HDM-2 protein expressed on their membranes. Research indicates it induces membrane lysis (necrosis) specifically in tumor cells while leaving healthy cells unharmed. It is currently being studied in preclinical models for its potential as a targeted anti-cancer therapeutic.

Unknown (Preclinical research only)

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.